The Agra Fake Drug Syndicate: A Multi-Crore Criminal Enterprise Threatening Public Health
The Agra fake drug syndicate represents one of India’s most extensive pharmaceutical counterfeiting operations, spanning multiple states and involving sophisticated criminal networks that have distributed counterfeit medicines worth hundreds of crores. This comprehensive investigation reveals how a well-organized criminal enterprise exploited regulatory gaps to manufacture and distribute fake medications across the country, posing severe risks to public health and undermining trust in India’s pharmaceutical system.
The Scale of the Criminal Operation
The Uttar Pradesh Special Task Force (STF) and state drug department’s investigation, which began intensively in August 2025, exposed a syndicate that had been operating fake medicine distribution networks worth over ₹200 crores. The operation involved multiple interconnected businesses across Agra and Lucknow, with supply chains extending from Chennai and Puducherry manufacturing hubs to distribution networks spanning 12 states and extending internationally to Nepal and Bangladesh. [1][2]
The most significant breakthrough came with the raid on Hema Medical, owned by Himanshu Agarwal, where authorities seized drugs worth ₹3.5 crores and discovered an additional ₹60 crores worth of stored pharmaceutical products. The investigation revealed that Agarwal had attempted to bribe officials with ₹1 crore, delivered in three bags containing 200 bundles of ₹500 notes, highlighting the enormous profits generated by this illegal trade. [3][4][1]
Major operations and drug seizures in the Agra fake drug syndicate case, showing values in crores of rupees
Key Criminal Networks and Operations
The Himanshu Agarwal Network
Himanshu Agarwal emerged as a central figure in the syndicate, operating through Hema Medical and utilizing sophisticated methods to distribute counterfeit medicines. His network used fake bills and QR codes to legitimize the sale of counterfeit medicines, creating an appearance of authenticity that allowed widespread distribution. The investigation revealed that his operation stored drugs worth ₹60 crores and was actively involved in manufacturing fake medicines of well-known companies, including treatments for colds, coughs, diabetes, and pain relief. [1][3]
The Bansal Medical Complex
The Bansal Medical network, operated by Sanjay Bansal and associated family members including Mukesh Bansal and Sohit Bansal, represented another major component of the syndicate. Authorities seized drugs worth ₹10 crores from Bansal Medical Agency, while an additional facility, MSV Medi Point, contained medicines worth ₹80 lakhs. The GST investigation revealed significant discrepancies in the purchase and sale records, with authorities detecting a ₹1.10 crore difference in declared transactions. [1][5][6]
The Vijay Goyal Criminal Enterprise
Drug mafia Vijay Goyal operated one of the most sophisticated and persistent operations within the syndicate. Despite being arrested in July 2023 and having his factories in Sikandara and Bichpuri areas raided, Goyal resumed operations after his release on bail in February 2024. His network extended across 11 states, utilizing hawala money transfers and involving connections with other criminals, including cannabis smuggler Vishal Agarwal who provided ₹30 lakhs in funding. [7][8][9][10][11]
The October 2024 raid on Goyal’s renewed operation in Sikandara Industrial Area resulted in the seizure of counterfeit medicines worth ₹8 crores and machinery valued at ₹4 crores. The investigation revealed that his operation sourced raw materials and machinery from multiple states including Uttar Pradesh, Haryana, Delhi, and Himachal Pradesh, relocating operations every six months to evade detection. [10][7]
Manufacturing and Distribution Methods
Sophisticated Production Techniques
The syndicate employed advanced manufacturing techniques that made detection extremely difficult. The investigation revealed that criminals were manufacturing fake medicines with identical batch numbers to genuine products, producing up to 1000 times more counterfeit drugs from a single legitimate batch number. This method created an enormous multiplication effect, where one authentic batch could generate thousands of fake products distributed across multiple states. [12]
The manufacturing facilities utilized professional-grade machinery and equipment, with some operations housed in educational institutions to avoid suspicion. The July 2023 bust at an educational institute recovered fake drugs worth ₹5 crores, including counterfeit versions of popular medications such as Alzocel tablets, Appecef tablets, Corex, and Codistar cough syrup. [13]
Distribution Networks and Supply Chains
The syndicate’s distribution network demonstrated remarkable sophistication and geographic reach. Counterfeit medicines were transported through various methods, including state roadways buses, with operators paying drivers and conductors up to ₹2,000 per shipment to facilitate discrete transportation. This method allowed large quantities of fake medicines to be distributed across state boundaries without detection. [14]
The network extended internationally, with evidence of smuggling to Nepal and Bangladesh. Codeine syrup became a particular focus, with bottles originally costing ₹80-100 being sold for ₹500-600, generating enormous profit margins. The investigation revealed that 17 people were involved specifically in preparing fake syrups and adding narcotic tablets to them. [1]
Hospital and Medical Store Infiltration
A particularly concerning aspect of the operation was the infiltration of hospital-based medical stores and clinics. The investigation found that approximately 50% of the syndicate’s counterfeit drugs were being sold through medical stores operating within hospitals, making detection even more difficult as these locations typically face less regulatory scrutiny. This placement gave the fake medicines an appearance of legitimacy and increased patient trust. [12]
Regulatory Response and Law Enforcement Actions
Special Investigation Team Formation
In response to the scale of the criminal enterprise, Agra Police Commissioner formed a Special Investigation Team (SIT) comprising officers from more than a dozen departments. The SIT, headed by the Police Commissioner and including 15 inspectors and station house officers, was tasked with completely dismantling the drug syndicate operating in the region and beyond. [15][16]
The formation of this specialized team represented recognition of the complexity and scale of the criminal operation, requiring coordinated action across multiple jurisdictions and regulatory bodies. The SIT’s mandate extended beyond simple arrests to include property seizure and systematic dismantling of the entire network. [16][15]
Multi-Agency Coordination
The investigation involved unprecedented coordination between multiple agencies, including the UP Special Task Force, Food Safety and Drug Administration (FSDA), Anti Narcotics Task Force (ANTF), Income Tax Department, and GST authorities. This multi-pronged approach enabled authorities to address different aspects of the criminal enterprise simultaneously, from manufacturing and distribution to financial transactions and tax evasion.[1][5]
The GST investigation alone revealed discrepancies worth ₹1.10 crore in purchase and sale records, with evidence that the syndicate was using non-registered firms to claim fraudulent input tax credits. This financial dimension of the investigation highlighted how the criminals were exploiting multiple regulatory systems simultaneously.[5]
Impact on Public Health and Safety
Health Consequences of Counterfeit Medicines
The Agra fake drug syndicate posed severe threats to public health through the distribution of medicines containing incorrect ingredients, subtherapeutic doses, or dangerous contaminants. Counterfeit antimicrobial agents, in particular, can promote microbial resistance by providing insufficient active pharmaceutical ingredients, requiring patients to eventually use more potent medications and creating resistant pathogen strains. [17][18]
The use of substandard drugs can result in adverse side effects, treatment failure, resistance, toxicity, and even death. Patients suffering from chronic diseases face particular risks as the counterfeit medicines they consume may not contain correct active pharmaceutical ingredients or may have subtherapeutic concentrations. [19][17]
Economic Impact on Healthcare System
The economic consequences of the fake drug trade extend far beyond the immediate profits to criminals. Families deplete their savings on ineffective treatments, while healthcare systems waste precious resources on managing treatment failures and adverse reactions. The estimated annual economic loss due to counterfeit drugs in India averages ₹6.36 billion, with enforcement measures typically being reactionary rather than preventive. [17][20]
The economic model of the counterfeit trade preys on patients’ financial desperation, with genuine doses of branded biologics retailing between ₹1.5 lakh and ₹2 lakh, while counterfeit versions are sold for ₹50,000 to ₹70,000 per vial. This price differential creates strong market incentives for both suppliers and desperate patients, perpetuating the cycle of counterfeit drug distribution.[21]
Legal Framework and Enforcement Challenges
Current Legal Penalties
India’s legal framework for addressing counterfeit medicines involves multiple statutes with varying penalty structures. Under the Drugs and Cosmetics Act, 1940, individuals found guilty of manufacturing or selling fake medicines that cause grievous harm face imprisonment of 7-10 years, potentially extending to life imprisonment, along with fines of at least ₹10 lakhs or three times the value of confiscated drugs. [22][23]
The Indian Penal Code, 1860, provides for imprisonment up to six months or fines up to ₹1,000 for adulterating drugs or selling adulterated medicines. However, enforcement officials and industry experts argue that these penalties are insufficient to deter large-scale criminal operations given the enormous profits involved. [24][22]
Enforcement Limitations
Despite stringent laws on paper, enforcement faces significant challenges. The maximum punishment for distribution and sale of fake drugs under current law is imprisonment of up to three years, with most suspects released on bail well before serving their sentences. Cases involving patient deaths from fake medicines carry provisions for 10-year imprisonment, but such cases are extremely difficult to prove in court. [24]
The regulatory framework suffers from inadequate budgets and infrastructure for effective monitoring and control. State-level enforcement agencies often lack the resources necessary to conduct comprehensive investigations of sophisticated criminal networks spanning multiple states and involving complex financial transactions. [24]
Broader Context of India’s Counterfeit Drug Problem
National Scale of the Problem
The Agra syndicate represents part of a much larger national problem, with estimates suggesting that between 12-25% of all pharmaceuticals supplied in India are fake. According to health ministry estimates, 0.3% of medications in India are spurious and 5% are counterfeit, though industry organizations report higher figures of up to 15% of total medicines in the market being counterfeit or substandard. [25][24][20]
India has emerged as both a major producer and consumer of counterfeit medications, with states including Bihar, West Bengal, Uttar Pradesh, and Gujarat having the highest rates of counterfeit and spurious drug incidents. The pharmaceutical industry’s rapid growth, combined with India’s position as the world’s largest producer of generic pharmaceuticals, has created both opportunities for legitimate business and vulnerabilities for criminal exploitation. [26][25]
International Dimensions
The problem extends beyond India’s borders, with the country identified along with China and UAE as a major source of counterfeit drugs seized by the European Union. The international trade in fake medicines represents a global threat to public health, with counterfeit Indian-origin medicines found in markets across Africa, Southeast Asia, and other developing regions. [26]
The World Health Organization estimates that 1 in 10 medicinal products circulating in low- and middle-income countries is either substandard or falsified. All therapeutic categories have had falsified medicines found within them, with 150 countries impacted by pharmaceutical crime including falsified, diverted, or stolen pharmaceuticals. [27]
Prevention and Future Safeguards
Technology Solutions
Advanced technological solutions are being developed to combat counterfeit medicines, including blockchain tracking systems, AI-powered drug authentication, and enhanced QR code verification systems. These technologies could provide real-time authentication capabilities and create tamper-proof supply chain records that would make counterfeiting significantly more difficult. [20]
The implementation of sophisticated track-and-trace systems throughout the pharmaceutical supply chain could enable authorities to identify suspicious patterns and detect counterfeit products before they reach patients. However, such systems require significant investment in infrastructure and coordination among multiple stakeholders. [20]
Regulatory Improvements
Strengthening India’s regulatory framework requires enhanced coordination between central and state authorities, improved funding for enforcement agencies, and more stringent penalties that reflect the serious nature of pharmaceutical counterfeiting. The establishment of specialized courts for handling counterfeit drug cases could expedite prosecutions and ensure appropriate expertise in complex pharmaceutical crime cases. [28][29]
Enhanced international cooperation is essential given the cross-border nature of counterfeit drug networks. This includes information sharing among regulatory agencies, coordinated enforcement actions, and harmonized standards for detecting and prosecuting pharmaceutical crimes. [27][29]
Conclusion
The Agra fake drug syndicate represents a sophisticated criminal enterprise that exploited regulatory gaps and enforcement limitations to distribute counterfeit medicines worth hundreds of crores across multiple states and international borders. The investigation revealed networks involving dozens of individuals, complex financial arrangements, and distribution systems that infiltrated legitimate healthcare channels.
The case highlights the urgent need for comprehensive reforms to India’s pharmaceutical regulatory system, including enhanced enforcement capabilities, stronger penalties, improved inter-agency coordination, and adoption of advanced technological solutions for supply chain security. The formation of the Special Investigation Team and multi-agency response to the Agra syndicate provides a model for addressing similar criminal enterprises, but sustained commitment and resources will be required to effectively combat this ongoing threat to public health.
The broader implications extend beyond law enforcement to encompass fundamental questions about healthcare access, regulatory capacity, and the balance between promoting affordable generic medicines while maintaining quality and safety standards. As India continues to serve as a major supplier of pharmaceuticals globally, addressing the counterfeit drug problem becomes not just a national health imperative but an international responsibility with far-reaching consequences for global public health security.
- https://www.hindustantimes.com/cities/lucknow-news/multicrore-fake-medicines-syndicate-operating-from-agra-lucknow-exposed-101756650390772.html
- https://www.jagran.com/uttar-pradesh/agra-city-agra-fake-medicine-racket-send-drugs-in-puducherry-50-firms-noticed-24032838.html
- https://timesofindia.indiatimes.com/city/agra/man-held-for-rs-1-cr-bribe-rs-3-cr-fake-medicines-seized/articleshow/123487424.cms
- https://medicaldialogues.in/news/industry/pharma/rs-1-crore-bribe-to-drug-officials-exposed-up-stf-busts-multi-crore-fake-drugs-syndicate-154178
- https://www.amarujala.com/uttar-pradesh/agra/agra-fake-drug-syndicate-gst-team-caught-1-10-crore-difference-investigation-will-be-on-many-firm-2025-08-30
- https://www.amarujala.com/uttar-pradesh/agra/agra-fake-drug-syndicate-medicines-worth-80-lakhs-found-in-medicine-warehouse-2025-08-30
- https://www.indiatoday.in/cities/agra/story/uttar-pradesh-agra-police-fake-drug-factory-busted-2622162-2024-10-23
- https://www.amarujala.com/uttar-pradesh/agra/drug-mafia-vijay-goyal-gang-leader-gangster-charges-against-10-members-including-his-wife-2025-03-24
- https://medicarepharmabusiness.com/drug-mafia-in-agra-revealed-secret-of-supplies/
- https://www.jagran.com/uttar-pradesh/agra-city-raid-on-fake-drug-factory-drug-mafia-vijay-goyal-reopens-fake-drugs-factory-team-caught-machines-worth-rs-8-crore-23820281.html
- https://www.amarujala.com/uttar-pradesh/agra/hawala-connection-of-fake-and-intoxicating-drugs-big-revelation-in-interrogation-of-mafia-vijay-goyal-2024-10-24
- https://www.amarujala.com/uttar-pradesh/agra/fake-medicines-racket-exposed-in-hospital-medical-stores-71-crore-drugs-seized-in-agra-and-other-states-2025-09-02
- https://medicaldialogues.in/news/industry/pharma/agra-fake-drug-producing-unit-busted-at-educational-institute-drugs-fake-medicines-worth-rs-5-crore-recovered-114256
- https://pharmacypro.io/news/former-jan-aushadhi-kendra-operator-arrested-for-fake-drug-sales-in-agra
- https://www.jagran.com/uttar-pradesh/agra-city-agra-police-forms-sit-to-bust-fake-drug-syndicate-24030848.html
- https://www.uniindia.com/news/north/crime-up-drug-syndicate-sit/3561572.html
- https://www.scielo.br/j/bjps/a/bMLbQwpKyXPnBdmmgBTMt6y/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC2845817/
- https://www.uspharmacist.com/article/counterfeit-meds
- https://www.jetir.org/papers/JETIR2503890.pdf
- https://www.newindianexpress.com/cities/delhi/2025/Jul/14/capitals-deadly-dose-of-deception
- https://ssrana.in/articles/counterfeit-medicines-civil-criminal-remedies/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC1142494/
- https://economictimes.com/industry/healthcare/biotech/pharmaceuticals/surge-in-fake-medicines-in-retail-markets-leaving-druggists-distraught-traders-body/articleshow/118765250.cms
- https://ijopp.org/sites/default/files/2025/06/InJPharPract-18-4-352.pdf
- https://journalofsocialsciences.org/vol6no1/combating-counterfeit-and-substandard-medicines-in-india–legal-framework-and-the-way-ahead/
- https://www.ifpma.org/areas-of-work/improving-health-security/falsified-medicines/
- https://theprint.in/health/india-has-a-substandard-fake-drugs-problem-lack-of-recall-law-scrutiny-is-making-matters-worse/2304590/
- https://www.who.int/news-room/fact-sheets/detail/substandard-and-falsified-medical-products
- https://www.taxtmi.com/news?id=53790
- https://www.youtube.com/watch?v=h-jNAiUVroc
- https://www.jagran.com/uttar-pradesh/agra-city-agra-raid-on-fake-drug-agency-shop-sealed-amidst-investigation-24026827.html
- https://drugscontrol.org/news-detail.php?newsid=43010
- https://www.amarujala.com/uttar-pradesh/agra/fake-medicines-racket-of-223-crore-exposed-in-agra-buyers-under-scrutiny-2025-09-05
- https://indianexpress.com/article/cities/delhi/fake-medicine-racket-busted-operating-from-agra-and-lucknow-4-held-10238468/
- https://drugscontrol.org/news-detail.php?newsid=43044
- https://narcoticsindia.nic.in
- https://drugs.delhi.gov.in
- https://www.india.gov.in/food-safety-drug-administration-govt
- https://fsdaup.gov.in
- https://www.dcoiwa.com/List.up.pdf
- https://ijprajournal.com/issue_dcp/A Comprehensive Study of the Issue of Fake Drugs in the Indian Market.pdf
- https://www.sciencedirect.com/science/article/pii/S1477893924000759
- https://cdsco.gov.in/opencms/opencms/en/State-Drugs-Control/
- https://www.reuters.com/world/india/india-flags-quality-issues-with-some-widely-used-antacids-paracetamol-2024-09-26/
- https://www.fda.gov/drugs/buying-using-medicine-safely/counterfeit-medicine
- https://www.indialawoffices.com/legal-articles/anti-counterfeiting-laws-in-india
- https://timesofindia.indiatimes.com/city/agra/up-police-bust-rs-2-crore-fake-supplement-racket-in-muzaffarnagar/articleshow/123263694.cms
- https://www.indiacode.nic.in/show-data?actid=AC_CEN_12_13_00023_194023_1523353460112&orderno=43
- https://drugscontrol.org/news-detail.php?newsid=40626
- https://www.amarujala.com/uttar-pradesh/agra/fake-medicines-agra-71-crore-seized-traders-arrested-2025-09-01
- https://www.youtube.com/watch?v=Fap-rxSUZIs
- https://ppl-ai-code-interpreter-files.s3.amazonaws.com/web/direct-files/652c86f8b35b64b725c70477d38d7d2a/2d25a760-d6a2-4389-92ed-04962b111e86/95df873f.csv
- https://ppl-ai-code-interpreter-files.s3.amazonaws.com/web/direct-files/652c86f8b35b64b725c70477d38d7d2a/2d25a760-d6a2-4389-92ed-04962b111e86/a729c152.csv
- https://ppl-ai-code-interpreter-files.s3.amazonaws.com/web/direct-files/652c86f8b35b64b725c70477d38d7d2a/2d25a760-d6a2-4389-92ed-04962b111e86/a4b40c32.csv
- https://ppl-ai-code-interpreter-files.s3.amazonaws.com/web/direct-files/652c86f8b35b64b725c70477d38d7d2a/2d25a760-d6a2-4389-92ed-04962b111e86/6095e681.csv
